Survival Outcomes Associated with First-Line PCV or Temozolomide in Combination with Radiotherapy in IDH-mutant 1P/19q-Codeleted Grade 3 Oligodendroglioma. Salah Eddine O. Kacimi,Caroline Dehais,Loic Feuvret,Olivier L. Chinot,Catherine Carpentier,Charlotte Bronnimann,Elodie Vauleon,Apolline Djelad,Elizabeth L. Cohen-Jonathan Moyal,Olivier Langlois,Mario Campone,Mathilde Ducloie,Georges Noel,Stefania Cuzzubbo,Damien Ricard,Thierry Faillot, Pierre-Yves Boelle,Dominique Figarella-Branger,Francois Ducray,Mehdi TouatJOURNAL OF CLINICAL ONCOLOGY(2024)引用 0|浏览29暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要